Conditional up-regulation of IL-2 production by p38 MAPK inactivation is mediated by increased Erk1/2 activity

Journal of Leukocyte Biology

Volumn 79, Issue 5, 2006, Pages 1052-1060

  Kogkopoulou, Olga ^a   Tzakos, Evaggelos ^a   Mavrothalassitis, George ^b   Baldari, Cosima T ^c   Paliogianni, Fotini ^d   Young, Howard A ^e   Thyphronitis, George ^a,f,g  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF PATRAS   (Greece)

^e NATIONAL CANCER INSTITUTE   (United States)

^f CNRS   (France)

^g INSTITUT ANDRÉ LWOFF   (France)

Author keywords

Protein kinases; Signal transduction; T lymphocytes; Transcription factors

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 ETHYL 2 (4 METHOXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 (4 FLUOROPHENYL) 2,3 DIHYDRO 5 (4 PYRIDYL)IMIDAZO[2,1 B]THIAZOLE; CYTOKINE; IMIDAZOLE DERIVATIVE; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RIBONUCLEASE; SYNAPTOPHYSIN; UO 126; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PROMOTER REGION;

EUKARYOTA; PYRONIA TITHONUS;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 33745297835     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0705418     Document Type: Article

References (39)

1. Iwashima, M. (2003) Kinetic perspectives of T cell antigen receptor signaling. A two-tier model for T cell full activation. Immunol. Rev. 191, 196-210.
2. Dong, C., Davis, R. J., Flavell, R. A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72.
3. Rincon, M. (2001) MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13, 339-345.
4. Dumont, F. J., Staruch, M. J., Fischer, P., DaSilva, C., Camacho, R. (1998) Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. 160, 2579-2589.
5. Genot, E., Cleverley, S., Henning, S., Cantrell, D. (1996) Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J. 15, 3923-3933.
6. Faris, M., Kokot, N., Lee, L., Nel, A. E. (1996) Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation. J. Biol. Chem. 271, 27366-27373.
7. Koike, T., Yamagishi, H., Hatanaka, Y., Fukushima, A., Chang, J. W., Xia, Y., Fields, M., Chandler, P., Iwashima, M. (2003) A novel ERK-dependent signaling process that regulates interleukin-2 expression in a late phase of T cell activation. J. Biol. Chem. 278, 15685-15692.
8. Whitmarsh, A. J., Davis, R. J. (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74, 589-607.
9. Young, M. R., Nair, R., Bucheimer, N., Tulsian, P., Brown, N., Chapp, C., Hsu, T. C., Colburn, N. H. (2002) Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol. Cell. Biol. 22, 587-598.
10. Treinies, I., Paterson, H. F., Hooper, S., Wilson, R., Marshall, C. J. (1999) Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell. Biol. 19, 321-329.
11. Matsuda, S., Moriguchi, T., Koyasu, S., Nishida, E. (1998) T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273, 12378-12382.
12. Chen, C. Y., Gherzi, R., Andersen, J. S., Gaietta, G., Jurchott, K., Royer, H. D., Mann, M., Karin, M. (2000) Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 14, 1236-1248.
13. Dong, C., Yang, D. D., Tournier, C., Whitmarsh, A. J., Xu, J., Davis, R. J., Flavell, R. A. (2000) JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91-94.
14. Zhang, J., Salojin, K. V., Gao, J. X., Cameron, M. J., Bergerot, I., Delovitch, T. L. (1999) p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J. Immunol. 162, 3819-3829.
15. Song, G. Y., Chung, C. S., Chaudry, I. H., Ayala, A. (2000) Immune suppression in polymicrobial sepsis: differential regulation of Th1 and Th2 responses by p38 MAPK. J. Surg. Res. 91, 141-146.
16. Koprak, S., Staruch, M. J., Dumont, F. J. (1999) A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell. Immunol. 192, 87-95.
17. Mori, A., Kaminuma, O., Miyazawa, K., Ogawa, K., Okudaira, H., Akiyama, K. (1999) p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis. J. Immunol. 163, 4763-4771.
18. Schafer, P. H., Wadsworth, S. A., Wang, L., Siekierka, J. J. (1999) p38 α mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells. J. Immunol. 162, 7110-7119.
19. Veiopoulou, C., Kogopoulou, O., Tzakos, E., Mavrothalassitis, G., Mitsias, D., Karafoulidou, A., Paliogianni, F., Moutsopoulos, H. M., Thyphronitis, G. (2004) IL-2 and IL-10 production by human CD4+T cells is differentially regulated by p38: mode of stimulation-dependent regulation of IL-2. Neuroimmunomodulation 11, 199-208.
20. Taetle, R., To, D., Caviles, A., Norby, S. W., Mendelsohn, J. (1983) Characterization of normal peripheral blood lymphocyte colony-forming cells: cell cycle status, surface markers, and cellular growth requirements. Blood 61, 548-555.
21. Le Gallic, L., Sgouras, D., Beal Jr., G., Mavrothalassitis, G. (1999) Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation. Mol. Cell. Biol. 19, 4121-4133.
22. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C. Y., Shyu, A. B., Muller, M., Gaestel, M., Resch, K., Holtmann, H. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18, 4969-4980.
23. Northrop, J. P., Ullman, K. S., Crabtree, G. R. (1993) Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J. Biol. Chem. 268, 2917-2923.
24. Li, S. P., Junttila, M. R., Han, J., Kahari, V. M., Westermarck, J. (2003) p38 mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2. Cancer Res. 63, 3473-3477.
25. Numazawa, S., Watabe, M., Nishimura, S., Kurosawa, M., Izuno, M., Yoshida, T. (2003) Regulation of ERK-mediated signal transduction by p38 MAP kinase in human monocytic THP-1 cells. J. Biochem. (Tokyo) 133, 599-605.
26. Frasch, S. C., Nick, J. A., Fadok, V. A., Bratton, D. L., Worthen, G. S., Henson, P. M. (1998) p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273, 8389-8397.
27. Whitehurst, C. E., Geppert, T. D. (1996) MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 156, 1020-1029.
28. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A., Trzaskos, J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
29. Lee, J., Hong, F., Kwon, S., Kim, S. S., Kim, D. O., Kang, H. S., Lee, S. J., Ha, J. (2002) Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation. Biochem. Biophys. Res. Commun. 298, 765-771.
30. Singh, R. P., Dhawan, P., Golden, C., Kapoor, G. S., Mehta, K. D. (1999) One-way cross-talk between p38(MAPK) and p42/44(MAPK). Inhibition of p38(MAPK) induces low density lipoprotein receptor expression through activation of the p42/44(MAPK) cascade. J. Biol. Chem. 274, 19593-19600.
31. Leitenberg, D., Bottomly, K. (1999) Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin. Immunol. 11, 283-292.
32. Duckworth, B. C., Cantley, L. C. (1997) Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength. J. Biol. Chem. 272, 27665-27670.
33. Schade, A. E., Levine, A. D. (2004) Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength. J. Immunol. 172, 5828-5832.
34. Jorritsma, P. J., Brogdon, J. L., Bottomly, K. (2003) Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J. Immunol. 170, 2427-2434.
35. Balmanno, K., Cook, S. J. (1999) Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18, 3085-3097.
36. Murphy, L. O., Smith, S., Chen, R. H., Fingar, D. C., Blenis, J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564.
37. Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y. S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., Hewett, T. E., Molkentin, J. D. (2003) Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J. Clin. Invest. 111, 1475-1486.
38. Zhang, H., Shi, X., Hampong, M., Blanis, L., Pelech, S. (2001) Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J. Biol. Chem. 276, 6905-6908.
39. Westermarck, J., Li, S. P., Kallunki, T., Han, J., Kahari, V. M. (2001) p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol. Cell. Biol. 21, 2373-2383.